Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Boon

Showing results (211-220 of 224) with videos related to

Pageof 23
Sort By:
Blood|August 10, 1999
Genes encoding tumor-specific antigens are expressed in human myeloma cellsN van Baren, F Brasseur, D Godelaine, et al.
Cold Spring Harbor Symposia on Quantitative Biology|January 1, 1994
Genes coding for tumor-specific rejection antigensT Boon, B Van den Eynde, H Hirsch, et al.
The Journal of Experimental Medicine|July 1, 1994
A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomasP G Coulie, V Brichard, A Van Pel, et al.
Biological Research for Nursing|February 4, 2026
Sex Differences in Pain Sensitivity Among Cognitively Healthy Older AdultsAaron L McDaniel, Jeffrey T Boon, Todd B Monroe, et al.
The Journal of Experimental Medicine|February 1, 1996
An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteinsJ C Skipper, R C Hendrickson, P H Gulden, et al.
European Journal of Immunology|February 17, 1998
Control of B cell lymphoma recognition via natural killer inhibitory receptors implies a role for human Vgamma9/Vdelta2 T cells in tumor immunityP Fisch, E Meuer, D Pende, et al.
International Journal of Cancer|October 23, 1997
Identification of HLA-A*0201-restricted CTL epitopes encoded by the tumor-specific MAGE-2 gene productM J Visseren, S H van der Burg, E I van der Voort, et al.
International Journal of Cancer|June 11, 1996
Infrequent expression of the MAGE gene family in uveal melanomasK A Mulcahy, D Rimoldi, F Brasseur, et al.
Tissue Antigens|January 23, 1999
Mutations of the beta2-microglobulin gene result in a lack of HLA class I molecules on melanoma cells of two patients immunized with MAGE peptidesR Benitez, D Godelaine, M A Lopez-Nevot, et al.
Immunity|February 8, 2000
Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cellsS Morel, F Lévy, O Burlet-Schiltz, et al.
Pageof 23

Showing results (211-220 of 224) with videos related to

Sort By:
Pageof 23
Blood|August 10, 1999
Genes encoding tumor-specific antigens are expressed in human myeloma cellsN van Baren, F Brasseur, D Godelaine, et al.
Cold Spring Harbor Symposia on Quantitative Biology|January 1, 1994
Genes coding for tumor-specific rejection antigensT Boon, B Van den Eynde, H Hirsch, et al.
The Journal of Experimental Medicine|July 1, 1994
A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomasP G Coulie, V Brichard, A Van Pel, et al.
Biological Research for Nursing|February 4, 2026
Sex Differences in Pain Sensitivity Among Cognitively Healthy Older AdultsAaron L McDaniel, Jeffrey T Boon, Todd B Monroe, et al.
The Journal of Experimental Medicine|February 1, 1996
An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteinsJ C Skipper, R C Hendrickson, P H Gulden, et al.
European Journal of Immunology|February 17, 1998
Control of B cell lymphoma recognition via natural killer inhibitory receptors implies a role for human Vgamma9/Vdelta2 T cells in tumor immunityP Fisch, E Meuer, D Pende, et al.
International Journal of Cancer|October 23, 1997
Identification of HLA-A*0201-restricted CTL epitopes encoded by the tumor-specific MAGE-2 gene productM J Visseren, S H van der Burg, E I van der Voort, et al.
International Journal of Cancer|June 11, 1996
Infrequent expression of the MAGE gene family in uveal melanomasK A Mulcahy, D Rimoldi, F Brasseur, et al.
Tissue Antigens|January 23, 1999
Mutations of the beta2-microglobulin gene result in a lack of HLA class I molecules on melanoma cells of two patients immunized with MAGE peptidesR Benitez, D Godelaine, M A Lopez-Nevot, et al.
Immunity|February 8, 2000
Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cellsS Morel, F Lévy, O Burlet-Schiltz, et al.
Pageof 23